Early intervention for major depressive disorder could lead to better outcomes

Real-world data, presented at the American Psychiatric Association Meeting (18–22 May 2019; CA, USA), suggests that treatment in the year prior to diagnosis of suicide ideation or attempt is markedly low for adult patients with major depressive disorder. Real-world data from three studies, from Janssen Pharmaceutical Companies (Beerse, Belgium), suggests that there is a need to increase and improve interventions for adult patients with major depressive disorder (MDD). In their findings, they saw that treatments for these patients were noticeably low a year prior to diagnosis of suicide prevention or attempt. "Sadly, approximately 47,000 people in the US died by...